M. Nooij

Randomised trial of two regimens of chemotherapy in operable osteosarcoma: a study of the European Osteosarcoma Intergroup

Robert L. Souhami, Alan Craft, Jan W. van der Eijken et al. · The Lancet · 1997 · 381 citations

Surgical Oncology, Medicine, Cancer Management +9

Improvement in Histologic Response But Not Survival in Osteosarcoma Patients Treated With Intensified Chemotherapy: A Randomized Phase III Trial of the European Osteosarcoma Intergroup

Ian Lewis, M. Nooij, Jeremy Whelan et al. · JNCI Journal of the National Cancer Institute · 2007 · 344 citations · Full text

Phase III Study Comparing Exemestane With Tamoxifen As First-Line Hormonal Treatment of Metastatic Breast Cancer in Postmenopausal Women: The European Organisation for Research and Treatment of Cancer Breast Cancer Cooperative Group

Robert Paridaens, Luc Dirix, L.V.A.M. Beex et al. · Journal of Clinical Oncology · 2008 · 319 citations · Full text

High-Dose Chemotherapy with Hematopoietic Stem-Cell Rescue for High-Risk Breast Cancer

Sjoerd Rodenhuis, M. Bontenbal, L.V.A.M. Beex et al. · New England Journal of Medicine · 2003 · 259 citations · Full text

Mature results of a randomized phase II multicenter study of exemestane versus tamoxifen as first-line hormone therapy for postmenopausal women with metastatic breast cancer

Robert Paridaens, Luc Dirix, Caroline Lohrisch et al. · Annals of Oncology · 2003 · 230 citations

Metastatic Breast Cancer, Breast Oncology, Medicine +10